BNBX Pivots to BNB-Centric Digital Asset Strategy, Secures $26.8M

TL;DR

**BNBX is going all-in on BNB yield farming, a high-risk, high-reward bet on crypto that could either moon or bust.**

AI Summary

BNB PLUS CORP. (BNBX) pivoted to a digital asset treasury (DAT) strategy in October 2025, focusing on accumulating and generating yield from BNB, the native cryptocurrency of the Binance blockchain ecosystem. This strategic shift was initiated with a private placement offering that secured $26.8 million in gross proceeds from cash and cryptocurrency assets, with potential for an additional $30.8 million from warrant exercises. The company plans to generate yield through Binance Launch Pool airdrops, native staking on Binance Smart Chain, liquidity providing on DEXs, and BNB collateralization for non-directional DeFi strategies. Concurrently, its LineaRx, Inc. subsidiary continues to commercialize nucleic acid production solutions for biopharmaceutical and diagnostics markets. A significant portion of BNB exposure is currently held in OBNB Osprey BNB Chain Trust Units, which the company intends to sell or redeem for underlying BNB to further its strategy. The company acknowledges substantial risks, including the highly volatile nature of BNB, regulatory uncertainties, and dependence on Binance's ecosystem and its founder's holdings.

Why It Matters

BNBX's aggressive pivot to a BNB-focused digital asset treasury strategy marks a significant shift, potentially offering high returns but also exposing investors to extreme cryptocurrency volatility and regulatory risks. This move places BNBX in direct competition with other crypto-focused investment vehicles and could impact its traditional biopharmaceutical subsidiary, LineaRx. Employees and customers of LineaRx might face uncertainty as the company's primary focus shifts. The broader market will watch how BNBX navigates the complex and evolving regulatory landscape for digital assets, especially concerning BNB's burn mechanism and Binance's market influence, setting a precedent for similar corporate treasury strategies.

Risk Assessment

Risk Level: high — The risk level is high due to the company's primary strategy being centered on BNB, a highly volatile cryptocurrency. The filing explicitly states, "the highly volatile nature of the price of BNB and other cryptocurrencies" and highlights risks related to "significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally." Furthermore, the company's dependence on Binance and its founder, who reportedly holds a significant majority of BNB, introduces substantial counterparty and reputational risks, as noted in the filing.

Analyst Insight

Investors should exercise extreme caution and conduct thorough due diligence on the inherent volatility and regulatory risks associated with cryptocurrency investments, specifically BNB. Consider the speculative nature of this pivot and its potential impact on the LineaRx subsidiary's value before making any investment decisions.

Financial Highlights

debt To Equity

0.0

revenue

$0

operating Margin

N/A

total Assets

$26.8M

total Debt

$0

net Income

$0

eps

$0

gross Margin

N/A

cash Position

$26.8M

revenue Growth

N/A

Revenue Breakdown

Key Numbers

• $26.8M — Gross proceeds from Private Placement (Initial funding for BNB Strategy in October 2025)
• $30.8M — Potential additional gross proceeds (From future warrant exercises, further funding the BNB Strategy)
• $10.5M — Aggregate market value of non-affiliate common stock (As of March 31, 2025, indicating a smaller market capitalization)
• 4,365,541 — Shares of common stock outstanding (As of December 15, 2025)
• 200M — Initial total supply of BNB tokens (Targeted to be reduced to 100 million through burn policy)
• 100M — Target total supply of BNB tokens (After burn policy implementation)
• 37M — BNB reportedly remaining to be burned (As of October 2025, to reach the 100 million target)
• 2,000+ — Maximum theoretical transactions per second on BNB Chain (Indicates high throughput capability)
• $0.01 — Approximate gas fees per transaction on BNB Chain (Facilitates wide user participation and micro-transactions)
• October 2025 — Launch of DAT strategy (Marks the company's strategic pivot)

Key Players & Entities

• BNB PLUS CORP. (company) — registrant
• BNBX (company) — ticker symbol
• Binance (company) — blockchain ecosystem and exchange
• BNB (dollar_amount) — native cryptocurrency
• LineaRx, Inc. (company) — subsidiary commercializing nucleic acid solutions
• U.S. Securities and Exchange Commission (regulator) — regulator of filings and potential cryptocurrency classification
• Osprey BNB Chain Trust (company) — trust holding BNB units
• $26.8 million (dollar_amount) — gross proceeds from private placement
• $30.8 million (dollar_amount) — potential additional gross proceeds from warrant exercises
• March 31, 2025 (date) — last business day of second fiscal quarter

FAQ

Risk Factors

• BNB Price Volatility [high — market]: The company's primary reserve asset is BNB, which is highly volatile. Its value can fluctuate significantly, impacting the company's treasury value and ability to generate yield. The company acknowledges substantial risks related to the volatile nature of BNB.
• Regulatory Uncertainty [high — regulatory]: The digital asset and cryptocurrency space faces significant and evolving regulatory uncertainty. Changes in regulations could adversely affect the company's ability to execute its BNB Strategy or the value of its BNB holdings. The company acknowledges substantial risks related to regulatory uncertainties.
• Dependence on Binance Ecosystem [high — operational]: The company's BNB Strategy is heavily reliant on the Binance ecosystem, including the Binance blockchain and its founder's holdings. Any disruptions or negative developments within the Binance ecosystem could materially impact the company's operations and strategy.
• Limited Operating History for DAT Strategy [medium — financial]: The digital asset treasury (DAT) strategy was launched in October 2025. The company has a limited operating history with this strategy, making it difficult to predict future performance or fully assess associated risks.
• Reliance on Private Placement and Warrant Exercises [medium — financial]: The company secured $26.8 million in gross proceeds from a private placement and has potential for an additional $30.8 million from warrant exercises. The success of the BNB Strategy is contingent on these funding sources.
• Liquidity of OBNB Osprey BNB Chain Trust Units [low — market]: The company holds OBNB Osprey BNB Chain Trust Units and intends to sell or redeem them for BNB. The liquidity and marketability of these units could impact the company's ability to convert them into BNB for its strategy.

Industry Context

The digital asset treasury (DAT) sector is rapidly evolving, driven by the increasing adoption of cryptocurrencies as alternative reserve assets. Companies in this space focus on yield generation through various DeFi protocols and blockchain ecosystem participation. The competitive landscape includes other digital asset managers and traditional financial institutions exploring crypto exposure. Key trends involve the development of more sophisticated yield-generating strategies and the increasing integration of blockchain technology into financial services.

Regulatory Implications

The digital asset industry faces significant regulatory scrutiny globally. BNB PLUS CORP.'s reliance on BNB and the Binance ecosystem exposes it to potential regulatory actions or changes that could impact its operations, the value of its assets, and its ability to conduct business. Compliance with evolving regulations is a critical challenge.

What Investors Should Do

1. Monitor BNB price volatility and Binance ecosystem developments.
2. Evaluate the success of the LineaRx subsidiary's commercialization efforts.
3. Track warrant exercise activity and its impact on funding.
4. Assess the company's ability to navigate regulatory changes in the digital asset space.

Key Dates

• 2025-10-01: Launch of Digital Asset Treasury (DAT) Strategy — Marks the company's strategic pivot to focus on accumulating and generating yield from BNB.
• 2025-10-01: Closing of Private Placement — Secured $26.8 million in gross proceeds to fund the initial phase of the BNB Strategy.
• 2025-03-31: Aggregate Market Value of Non-Affiliate Common Stock — Indicated a market capitalization of $10.5 million as of this date.
• 2025-12-15: Shares of Common Stock Outstanding — Reported 4,365,541 shares outstanding as of this date.
• 2025-10-01: BNB Token Burn Policy Target — The company aims to reduce the total supply of BNB tokens from an initial 200 million to 100 million.

Glossary

Digital Asset Treasury (DAT)

A strategy where a company uses digital assets, like cryptocurrencies, as its primary reserve asset to generate yield. (This is the core strategy of BNB PLUS CORP. as of October 2025.)

BNB

The native cryptocurrency of the Binance blockchain ecosystem. (BNB PLUS CORP. has adopted BNB as its primary reserve asset for its DAT strategy.)

Binance Smart Chain (BSC)

A blockchain network developed by Binance, supporting smart contracts and decentralized applications. (BNB PLUS CORP. plans to utilize native staking on BSC for yield generation.)

DeFi

Decentralized Finance, a system of financial services built on blockchain technology, offering alternatives to traditional finance. (BNB PLUS CORP. intends to engage in DeFi strategies, including collateralizing BNB, to produce yield.)

Airdrops

Distribution of cryptocurrency tokens to multiple wallet addresses, often as a promotion or reward, typically via staking. (BNB PLUS CORP. plans to participate in Binance Launch Pool airdrops to generate yield.)

Liquidity Providing

Depositing pairs of tokens into a decentralized exchange (DEX) liquidity pool to earn trading fees. (BNB PLUS CORP. plans to provide liquidity on DEXs to generate yield from swap fees.)

OBNB Osprey BNB Chain Trust Units

Units of a trust that holds BNB, which BNB PLUS CORP. currently possesses. (The company plans to sell or redeem these units to acquire more BNB for its strategy.)

Nucleic Acid Production Solutions

Proprietary technology for cell-free manufacturing of DNA and RNA for biopharmaceutical and diagnostic applications. (This is the business of the company's subsidiary, LineaRx, Inc.)

Year-Over-Year Comparison

As this is the initial 10-K filing detailing the new DAT strategy launched in October 2025, a direct comparison to a prior year's performance is not applicable. The company has transitioned from its previous operational focus to a digital asset treasury model, with $26.8 million in initial funding. Key metrics such as revenue and net income are currently zero for the DAT strategy, reflecting its nascent stage, while the focus is on asset accumulation and yield generation framework development.

Key Financial Figures

• $0.001 — ) on which registered Common Stock, $0.001 par value BNBX The Nasdaq Stock Mar
• $26.8 million — (as defined below) wherein we received $26.8 million gross proceeds in cash and cryptocurren
• $30.8 million — h the potential for up to an additional $30.8 million in cash gross proceeds in future invest
• $0.01 — on BNB Chain are relatively low, around $0.01 per transaction, facilitating wide user
• $3.32 — te Placement"), at an offering price of $3.32 per share, an aggregate of 4,620,485 sh
• $0.0001 — stock at a per share exercise price of $0.0001 (the "Cash Pre-Funded Warrants"), and S
• $3.82 — stock at a per share exercise price of $3.82 and (ii) entered into a securities purc

Filing Documents

• tmb-20250930x10k.htm (10-K) — 2746KB
• tmb-20250930xex21d1.htm (EX-21.1) — 7KB
• tmb-20250930xex23d1.htm (EX-23.1) — 2KB
• tmb-20250930xex23d2.htm (EX-23.2) — 3KB
• tmb-20250930xex31d1.htm (EX-31.1) — 13KB
• tmb-20250930xex31d2.htm (EX-31.2) — 13KB
• tmb-20250930xex32d1.htm (EX-32.1) — 8KB
• tmb-20250930xex32d2.htm (EX-32.2) — 8KB
• 0001104659-25-123342.txt ( ) — 11714KB
• tmb-20250930.xsd (EX-101.SCH) — 85KB
• tmb-20250930_cal.xml (EX-101.CAL) — 86KB
• tmb-20250930_def.xml (EX-101.DEF) — 368KB
• tmb-20250930_lab.xml (EX-101.LAB) — 627KB
• tmb-20250930_pre.xml (EX-101.PRE) — 559KB
• tmb-20250930x10k_htm.xml (XML) — 2028KB

BUSINESS

BUSINESS 5 ITEM 1A.

RISK FACTORS

RISK FACTORS 18 ITEM 1B. UNRESOLVED STAFF COMMENTS 51 ITEM 1C CYBERSECURITY 51 ITEM 2.

PROPERTIES

PROPERTIES 52 ITEM 3.

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 52 ITEM 4. MINE SAFETY DISCLOSURES 52 PART II ITEM 5. MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 53 ITEM 6. RESERVED 53 ITEM 7.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 53 ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 63 ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 63 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 64 ITEM 9A.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 64 ITEM 9B. OTHER INFORMATION 65 ITEM 9C DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 65 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 66 ITEM 11.

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 70 ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 75 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 77 ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 78 PART IV ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 79 ITEM 16 . FORM 10-K SUMMARY 79 2 Table of Contents PART I Forward-looking Information This Annual Report on Form 10-K (including but not limited to Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations") contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are intended to qualify for the "safe harbor" created by those sections. In addition, we may make forward-looking statements in other documents filed with or furnished to the Securities and Exchange Commission ("SEC"), and our management and other representatives may make forward-looking statements orally or in writing to analysts, investors, representatives of the media and others. These statements relate to future events or to our future operating or financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements can generally be identified by the fact that they do not relate strictly to historical or current facts and include, but are not limited to, statements using terminology such as "can", "may", "could", "should", "assume", "focus", "forecasts", "believe", "designed to", "will", "expect", "plan", "anticipate", "estimate", "potential", "position", "predicts", "strategy", "guidance", "intend", "budget", "seek", "project

BUSINESS

ITEM 1. BUSINESS. Overview We are a digital asset treasury ("DAT") company that has adopted BNB, the native cryptocurrency of the Binance blockchain ecosystem as our primary reserve asset. By using proceeds from financings, as well as potential cashflow from our operations, we seek to strategically accumulate BNB and utilize the accumulated BNB as a productive treasury asset to produce yield via Binance native and other decentralized (DeFi) finance opportunities. In addition, via our LineaRx, Inc. subsidiary ("LineaRx"), we are commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets. Our nucleic acid production solutions enable cell-free manufacturing of deoxyribonucleic acid ("DNA") and ribonucleic acid ("RNA"), which are essential components for a new generation of advanced biotherapeutics, such as gene therapies, adoptive cell therapies, messenger RNA therapeutics and DNA vaccines, as well as diagnostic applications. BNB Strategy We launched our DAT strategy in October 2025 with the closing of the Private Placement (as defined below) wherein we received $26.8 million gross proceeds in cash and cryptocurrency assets with the potential for up to an additional $30.8 million in cash gross proceeds in future investment from warrant exercises. Our current strategy is to primarily focus our resources on our BNB-focused DAT strategy wherein we manage digital assets, primarily in the native cryptocurrency of the Binance Coin blockchain commonly referred to as "BNB", including staking, restaking, and liquid staking of BNB, and participation in other unique Binance ecosystem and DeFi yield opportunities to contribute the BNB to the Company's treasury operations (together, the "BNB Strategy"). Currently, the Company is in the process of accumulating BNB tokens and building the framework necessary to implement its BNB Strategy. Once launched, we believe our BNB Strategy can produce potential yield via the impl

View Full Filing

View this 10-K filing on SEC EDGAR